跳至主要内容
临床试验/DRKS00029182
DRKS00029182已完成3 期

Prospective randomized trial to evaluate a multimodal digital app in the treatment of erectile dysfunction - EDDIG

Kranus Health GmbH0 个研究点目标入组 241 人开始时间: 2022年6月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
241

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
Male

入选标准

  • IIEF = 21 in IIEF-5-questionnaire
  • men over 18 years

排除标准

  • Patients with serious cardiac risk factors (moderate to severe risk according to the Princeton classification)
  • unstable or refractory angina pectoris, uncontrolled hypertension, congestive heart failure (NYHA class III-IV), high-risk arrhythmia (exercise-induced ventricular tachycardia, implanted internal cardioverter defibrillator with frequent shocks, and poorly controlled atrial fibrillation), obstructive hypertrophic cardiomyopathy with severe symptoms, and moderate to severe valve disease, particularly aortic stenosis)
  • Patients with myocardial infarction within the last six months
  • s/p. prostatectomy, radiation or seeds of the prostate
  • s/p bigger surgery in the small pelvis with likelihood of nerval damage (eg rectal resection, cystectomy)
  • nerval diseases (eg multiple sclerosis (MS), parkinson´s disease, apoplex, dementia, psychiatric diseases)
  • s/p trauma to the pelvis/penile region/spine Active autoinjection therapy (SKAT, MUSE)
  • Patients with orthopaedic conditions that do not allow to perform the extended pelvic floor exercises

研究者

相似试验